Treatment of primary hyperhidrosis with oral anticholinergic medications: a systematic review

@article{Cruddas2017TreatmentOP,
  title={Treatment of primary hyperhidrosis with oral anticholinergic medications: a systematic review},
  author={Lucinda Cruddas and Daryll M. Baker},
  journal={Journal of the European Academy of Dermatology and Venereology},
  year={2017},
  volume={31}
}
  • L. Cruddas, D. Baker
  • Published 2017
  • Medicine
  • Journal of the European Academy of Dermatology and Venereology
Primary hyperhidrosis is a condition characterized by excessive sweating. Patients are treated off‐license with oral anticholinergic medications and report adverse events associated with systemic anticholinergic interactions. This review assesses clinical evidence of efficacy, impact on quality of life and adverse events associated with oral anticholinergic therapy for primary hyperhidrosis. PRISMA guidelines were implemented to complete a systematic review (PROSPERO:CRD42016036326). MEDLINE… Expand
Safety of available and emerging drug therapies for hyperhidrosis
TLDR
Efficacy and safety data on aluminum salts, anticholinergic drugs for topical or systemic application, and on intradermal botulinum toxin injections used to treat hyperhidrosis are critically evaluated, including data from clinical trials with focus on possible side effects and long-term complications in dispute. Expand
Survival study of treatment adherence by patients given oral glycopyrrolate for hyperhidrosis following treatment failure with oral oxybutynin
TLDR
The main variables associated with treatment adherence by patients receiving OGly, for whom previous treatment with OOx had failed, were identified and provided valuable insights into the outcomes achieved when OGly is used to treat hyperhidrosis. Expand
Cost-effectiveness of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis.
TLDR
Glycopyrronium tosylate as first-line topical therapy compared to topical aluminum chloride from a United States commercial perspective may be cost-effective relative to prescription aluminum chloride at commonly accepted willingness to pay thresholds. Expand
Management Strategies Of Palmar Hyperhidrosis: Challenges And Solutions
TLDR
This review will provide an update on current and emerging concepts of management for excessive hand sweating to help clinicians optimize therapeutic decision-making. Expand
Oxybutynin in primary hyperhidrosis: A long‐term real‐life study
TLDR
This real life study suggests that oxybutynin is effective and safe for treatment of hyperhidrosis, both in children and adults, with mild and tolerable side effects, with significant improvement in HDSS. Expand
Stepwise treatment of primary focal hyperhidrosis with aluminum chloride hexahydrate lotion (20%) and oral glycopyrrolate: a retrospective study from a tertiary care center
TLDR
Addition of OGP to topical ACH increases the treatment efficacy in patients with primary focal hyperhidrosis and increasing the glycopyrrolate dose augments the response further. Expand
HYPERHIDROSIS TABLE 2 Select Medications That May Cause Secondary Hyperhidrosis Antidepressants
Hyperhidrosis is excessive swea"ting that affects patients’ quality of life, resulting in social and work impairment and emotional distress. Primary hyperhidrosis is bilaterally symmetric, focal,Expand
Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study
TLDR
A sequencing therapeutic approach to palmar hyperhidrosis increases both efficacy and safety compared with the use of oral oxybutynin chloride alone, and allows clinicians to keep lower dosage of oxybutYNin chloride reducing generalized side effects and increasing the retention rate to the treatment. Expand
Examining hyperhidrosis: an update on new treatments.
  • C. Jacob
  • Medicine
  • The American journal of managed care
  • 2018
TLDR
New treatment modalities, surgical procedures, associated comorbidities, and the impact on managed care of hyperhidrosis are discussed, so clinicians can tailor therapy, improve outcomes, and increase patient satisfaction. Expand
[Hyperhidrosis-aetiopathogenesis, diagnosis, clinical symptoms and treatment].
  • J. Wohlrab, B. Kreft
  • Medicine
  • Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
  • 2018
TLDR
Primary hyperhidrosis is a complex neuropathic dysregulation with a genetic predisposition and is diagnosed when patients show pathologic sweating patterns and excessive sweating for at least 6 months and fulfill at least four of the following criteria. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 39 REFERENCES
Systemic therapy for primary hyperhidrosis: a retrospective study of 59 patients treated with glycopyrrolate or clonidine.
  • H. Walling
  • Medicine
  • Journal of the American Academy of Dermatology
  • 2012
TLDR
Systemic therapy with glycopyrrolate or clonidine can be effective for HH, and nearly two-thirds responded to therapy, and less than a quarter had treatment-limiting adverse effects, all of which were self-limited and nonserious. Expand
Oral glycopyrrolate as second-line treatment for primary pediatric hyperhidrosis.
TLDR
Oral glycopyrrolate is a cost-effective, painless second-line therapy for children and adolescents with primary focal hyperhidrosis that impacts their quality of life. Expand
Efficacy of Glycopyrrolate in Primary Hyperhidrosis Patients
TLDR
Glycopyrrolate is an effective initial method of treating primary hyperhidrosis that, reduces anxiety and improve patients' quality of life. Expand
Primary focal hyperhidrosis: current treatment options and a step‐by‐step approach
  • I. Hoorens, K. Ongenae
  • Medicine
  • Journal of the European Academy of Dermatology and Venereology : JEADV
  • 2012
TLDR
The challenge for the dermatologist remains to evaluate the severity of hyperhidrosis to achieve the best therapeutic outcome, this can be done most effectively using the Hyperhidrosis Disease Severity Scale (HDSS). Expand
A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder.
TLDR
Efficacy and safety of different doses, formulations, and route of administration of the available anticholinergic drugs in patients with overactive bladder and more clinical studies are needed to indicate which of the drugs should be used as first-, second-, or third-line treatment. Expand
An alternative to treat palmar hyperhidrosis: use of oxybutynin
TLDR
The use of oxybutynin is an alternative as the first step in the treatment of palmar hyperhidrosis, given that it presents good results and improves QOL. Expand
Primary hyperhidrosis increases the risk of cutaneous infection: a case-control study of 387 patients.
  • H. Walling
  • Medicine
  • Journal of the American Academy of Dermatology
  • 2009
TLDR
The overall risk of any cutaneous infection was significantly increased in HH compared with controls and patients with HH are at high risk of secondary infection. Expand
Effectiveness of oxybutynin for treatment of hyperhidrosis in overweight and obese patients.
TLDR
Overweight and obese patients with palmar or axillary hyperhidrosis present significant improvement in QOL after treatment with oxybutynin, and the results are comparable to those of normal weight individuals. Expand
Compensatory hyperhidrosis: results of pharmacologic treatment with oxybutynin.
TLDR
Oxybutynin appears to be effective in treating bothersome CH, and more than 70% of patients presented with improved overall quality of life and improvement at the most prominent site of compensatory sweating. Expand
Treatment of uncommon sites of focal primary hyperhidrosis: experience with pharmacological therapy using oxybutynin
TLDR
Oxybutynin is effective for treating bothersome hyperhidrosis, even at atypical locations and most patients cope well with the side effects. Expand
...
1
2
3
4
...